CDER has established a meeting program called the Emerging Drug Safety Technology Meeting (EDSTM) program. Learn more.
Similar Posts
FDA Clinical Investigator Training Course (CITC) 2024 – 12/10/2024
FDA Clinical Investigator Training Course (CITC) 2024Antifungal Susceptibility Test Interpretive Criteria
Antifungal Susceptibility Test Interpretive CriteriaDarmerica, LLC – 716152 – 12/08/2025
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/MisbrandedInformation for Consumers and Patients | Drugs
Drug Information for Patients and ConsumersAzurity Pharmaceuticals, Inc. – 656489 – 09/20/2024
CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugAmish Origins Management, LLC – 704166 – 05/29/2025
CGMP/Finished Pharmaceuticals/Adulterated